Search - tctmd.com

Displaying 461 - 480 of 555

Sort: Relevancy | Date

Presentation TCT 2013

TCT-32. First Report of the Four Year Clinical Results of The ABSORB Trial Evaluating the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Patients...

Presenter: Bernard Chevalier

October 29, 2013

Presentation TCT 2013

TCT-31. ABSORB EXTEND: An Interim Report on the 24-month Clinical Outcomes from the First 250 Patients Enrolled

Presenter: Robert Whitbourn

October 29, 2013

News Industry News

Global Bifurcation Leader Tryton Medical Announces Events at TCT 2013

October 29, 2013

News Industry News

MiStent SES Shown to be Unique in Clinical Setting

October 29, 2013

Presentation TCT 2013

2 Cases: Absorb in a Distal Left Main Bifurcation and a Non Left Main Bifurcation

Presenter: Antonio Colombo

October 28, 2013

News Industry News

CRF and UCR Announce Initiation of PROSPECT II Clinical Trial

October 28, 2013

News Conference News TCT 2013

Bioresorbable Scaffold Stands Ground Next to Current DES

October 28, 2013

News Conference News TCT 2013

ABSORB III and IV Trials Aim to Prove Superiority of BVS

October 28, 2013

Presentation TCT 2013

Is ABSORB a Workhorse DES? Real-world Perspectives I

Presenter: Antonio Colombo

October 27, 2013

Presentation TCT 2013

The ABSORB III trial: Design, Goals and Enrollment Status

Presenter: Stephen Ellis

October 27, 2013

Presentation TCT 2013

Polylactic Acid Polymers: Chemistry and Structure in ABSORB 1.0 and 1.1

Presenter: Richard Rapoza

October 27, 2013

Presentation TCT 2013

Micro-CT Observations with ABSORB: Insights into Bifurcation Technique

Presenter: John Ormiston

October 27, 2013

Presentation TCT 2013

Lessons from Multimodality Imaging from ABSORB Cohort A (5 Years) and Cohort B (3 Years)

Presenter: Patrick Serruys

October 27, 2013

Presentation TCT 2013

Latest Results from ABSORB Extend: Comparison with Xience

Presenter: Bernard Chevalier

October 27, 2013

Presentation TCT 2013

It's Not a Metallic DES! Procedural Tips and Tricks to Optimizing ABSORB Outcomes

Presenter: Peter Smits

October 27, 2013

Presentation TCT 2013

Is ABSORB a Workhorse DES? Real-world Perspectives II

Presenter: Robert-Jan van Geuns

October 27, 2013

Presentation TCT 2013

Demonstration of Clinical Superiority with a Bioresorbable Vascular Scaffold: The ABSORB IV Clinical Trial

Presenter: Gregg Stone

October 27, 2013

News Daily News

High-Risk Subgroups Derive Kidney Protection from Rosuvastatin

Caitlin E. Cox

October 11, 2013

News Daily News

Los Subgrupos de Alto Riesgo obtienen Protección Renal de la Rosuvastatina

Caitlin E. Cox

October 11, 2013

News Daily News

DESSOLVE I: SLS de Polímero Bioabsorbible, Prometedor en Lesiones De Novo

Yael L. Maxwell

September 20, 2013

Advertisement

TCT-32. First Report of the Four Year Clinical Results of The ABSORB Trial Evaluating the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Patients...

TCT-31. ABSORB EXTEND: An Interim Report on the 24-month Clinical Outcomes from the First 250 Patients Enrolled

Global Bifurcation Leader Tryton Medical Announces Events at TCT 2013

MiStent SES Shown to be Unique in Clinical Setting

2 Cases: Absorb in a Distal Left Main Bifurcation and a Non Left Main Bifurcation

CRF and UCR Announce Initiation of PROSPECT II Clinical Trial

Bioresorbable Scaffold Stands Ground Next to Current DES

ABSORB III and IV Trials Aim to Prove Superiority of BVS

Is ABSORB a Workhorse DES? Real-world Perspectives I

The ABSORB III trial: Design, Goals and Enrollment Status

Polylactic Acid Polymers: Chemistry and Structure in ABSORB 1.0 and 1.1

Micro-CT Observations with ABSORB: Insights into Bifurcation Technique

Lessons from Multimodality Imaging from ABSORB Cohort A (5 Years) and Cohort B (3 Years)

Latest Results from ABSORB Extend: Comparison with Xience

It's Not a Metallic DES! Procedural Tips and Tricks to Optimizing ABSORB Outcomes

Is ABSORB a Workhorse DES? Real-world Perspectives II

Demonstration of Clinical Superiority with a Bioresorbable Vascular Scaffold: The ABSORB IV Clinical Trial

High-Risk Subgroups Derive Kidney Protection from Rosuvastatin

Los Subgrupos de Alto Riesgo obtienen Protección Renal de la Rosuvastatina

DESSOLVE I: SLS de Polímero Bioabsorbible, Prometedor en Lesiones De Novo

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content